These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8548000)
21. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Principi N; Esposito S Lancet Infect Dis; 2001 Dec; 1(5):334-44. PubMed ID: 11871806 [TBL] [Abstract][Full Text] [Related]
22. Management of bacterial infections in children with asthma. Korppi M Expert Rev Anti Infect Ther; 2009 Sep; 7(7):869-77. PubMed ID: 19735226 [TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of new antibacterial therapies in at-risk populations. Lorenz J J Infect; 2002 Feb; 44 Suppl A():25-30. PubMed ID: 12150492 [TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755 [TBL] [Abstract][Full Text] [Related]
25. Resistant respiratory pathogens and extended-spectrum antibiotics. Pichichero ME Am Fam Physician; 1995 Nov; 52(6):1739-46. PubMed ID: 7484684 [TBL] [Abstract][Full Text] [Related]
26. [Recent status and changes in respiratory tract infections]. Kouno S Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):529-33. PubMed ID: 9577588 [No Abstract] [Full Text] [Related]
27. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA; Ehrhardt AF; Jones RN Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [TBL] [Abstract][Full Text] [Related]
29. Susceptibility of streptococcus pneumoniae to fluoroquinolones and macrolides in upper respiratory tract infections. Mykhalko YO; Duhovych TV; Kish PP Wiad Lek; 2017; 70(2):224-226. PubMed ID: 28511165 [TBL] [Abstract][Full Text] [Related]
30. A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy. Seki M; Sakata T; Toyokawa M; Nishi I; Tomono K Intern Med; 2016; 55(3):307-10. PubMed ID: 26831030 [TBL] [Abstract][Full Text] [Related]
31. The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart. Khanna M; Fan J; Pehler-Harrington K; Waters C; Douglass P; Stallock J; Kehl S; Henrickson KJ J Clin Microbiol; 2005 Feb; 43(2):565-71. PubMed ID: 15695646 [TBL] [Abstract][Full Text] [Related]
32. Potential improvements in therapeutic options for mycoplasmal respiratory infections. Bébéar C; Dupon M; Renaudin H; de Barbeyrac B Clin Infect Dis; 1993 Aug; 17 Suppl 1():S202-7. PubMed ID: 8399917 [TBL] [Abstract][Full Text] [Related]
33. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Drusano GL; Craig WA J Chemother; 1997 May; 9 Suppl 3():38-44. PubMed ID: 9248979 [TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of ketolides in the treatment of respiratory tract infections. Reinert RR J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934 [TBL] [Abstract][Full Text] [Related]
35. Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections. Bruhn DF; Waidyarachchi SL; Madhura DB; Shcherbakov D; Zheng Z; Liu J; Abdelrahman YM; Singh AP; Duscha S; Rathi C; Lee RB; Belland RJ; Meibohm B; Rosch JW; Böttger EC; Lee RE Sci Transl Med; 2015 May; 7(288):288ra75. PubMed ID: 25995221 [TBL] [Abstract][Full Text] [Related]
36. Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections. Nicolau DP Am J Manag Care; 2004 Oct; 10(12 Suppl):S381-8. PubMed ID: 15603247 [No Abstract] [Full Text] [Related]
37. Telithromycin: the first ketolide for the treatment of respiratory infections. Kasbekar N; Acharya PS Am J Health Syst Pharm; 2005 May; 62(9):905-16. PubMed ID: 15851496 [TBL] [Abstract][Full Text] [Related]
38. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708 [TBL] [Abstract][Full Text] [Related]
39. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. Cizman M; Pokorn M; Seme K; Orazem A; Paragi M J Antimicrob Chemother; 2001 Apr; 47(4):475-7. PubMed ID: 11266425 [TBL] [Abstract][Full Text] [Related]
40. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Meyer Sauteur PM; van Rossum AM; Vink C Curr Opin Infect Dis; 2014 Jun; 27(3):220-7. PubMed ID: 24751894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]